Onyx Bridge Wealth Group LLC lowered its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 31.6% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 888 shares of the healthcare conglomerate’s stock after selling 410 shares during the period. Onyx Bridge Wealth Group LLC’s holdings in UnitedHealth Group were worth $465,000 as of its most recent SEC filing.
Several other large investors have also recently modified their holdings of UNH. Brighton Jones LLC raised its stake in shares of UnitedHealth Group by 176.2% during the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock valued at $22,384,000 after acquiring an additional 28,231 shares during the last quarter. Revolve Wealth Partners LLC raised its stake in UnitedHealth Group by 137.1% during the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock worth $2,033,000 after buying an additional 2,324 shares during the last quarter. Bank Pictet & Cie Europe AG raised its stake in UnitedHealth Group by 3.9% during the fourth quarter. Bank Pictet & Cie Europe AG now owns 263,655 shares of the healthcare conglomerate’s stock worth $133,373,000 after buying an additional 9,872 shares during the last quarter. Proficio Capital Partners LLC raised its stake in UnitedHealth Group by 52.1% during the fourth quarter. Proficio Capital Partners LLC now owns 3,734 shares of the healthcare conglomerate’s stock worth $1,889,000 after buying an additional 1,279 shares during the last quarter. Finally, Promus Capital LLC bought a new position in UnitedHealth Group during the fourth quarter worth $32,000. Institutional investors own 87.86% of the company’s stock.
Wall Street Analysts Forecast Growth
UNH has been the subject of a number of analyst reports. Bank of America downgraded shares of UnitedHealth Group from a “buy” rating to a “neutral” rating and lowered their target price for the stock from $560.00 to $350.00 in a research note on Wednesday, May 14th. Barclays reduced their price target on shares of UnitedHealth Group to $350.00 and set an “overweight” rating for the company in a report on Monday, June 2nd. Deutsche Bank Aktiengesellschaft reduced their price target on shares of UnitedHealth Group from $521.00 to $362.00 and set a “buy” rating for the company in a report on Wednesday, May 14th. KeyCorp reduced their price target on shares of UnitedHealth Group from $450.00 to $400.00 and set an “overweight” rating for the company in a report on Monday, June 2nd. Finally, Baird R W cut shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Wednesday, June 11th. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and sixteen have issued a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $415.57.
UnitedHealth Group Stock Up 0.4%
UnitedHealth Group stock opened at $308.69 on Friday. UnitedHealth Group Incorporated has a fifty-two week low of $248.88 and a fifty-two week high of $630.73. The stock has a market cap of $280.03 billion, a PE ratio of 12.93, a price-to-earnings-growth ratio of 1.48 and a beta of 0.45. The firm’s 50-day simple moving average is $324.99 and its 200 day simple moving average is $447.68. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.85 and a current ratio of 0.85.
UnitedHealth Group (NYSE:UNH – Get Free Report) last released its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. The firm had revenue of $109.58 billion for the quarter, compared to analysts’ expectations of $111.56 billion. During the same quarter last year, the firm posted $6.91 earnings per share. Research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.
UnitedHealth Group Increases Dividend
The business also recently announced a quarterly dividend, which was paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th were given a dividend of $2.21 per share. This is an increase from UnitedHealth Group’s previous quarterly dividend of $2.10. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.86%. The ex-dividend date was Monday, June 16th. UnitedHealth Group’s dividend payout ratio is currently 37.02%.
Insider Activity
In related news, CEO Stephen J. Hemsley bought 86,700 shares of UnitedHealth Group stock in a transaction dated Friday, May 16th. The stock was purchased at an average cost of $288.57 per share, with a total value of $25,019,019.00. Following the transaction, the chief executive officer directly owned 679,493 shares of the company’s stock, valued at approximately $196,081,295.01. The trade was a 14.63% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Kristen Gil bought 3,700 shares of UnitedHealth Group stock in a transaction dated Thursday, May 15th. The shares were bought at an average cost of $271.17 per share, with a total value of $1,003,329.00. Following the completion of the transaction, the director directly owned 3,818 shares in the company, valued at approximately $1,035,327.06. This trade represents a 3,135.59% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last ninety days, insiders purchased 109,408 shares of company stock worth $31,607,768. 0.28% of the stock is owned by insiders.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
See Also
- Five stocks we like better than UnitedHealth Group
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- The Apple Comeback Will Be Better Than the Setback
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- How a Government Loan Changes the Game for Plug Power
- CD Calculator: Certificate of Deposit Calculator
- Qualcomm’s Hold Rating Misses Strong Growth Story
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.